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Gain-of-function mutant of type 1A 
angiotensin II receptor
The angiotensin II (Ang II) receptor, type 1 (AT1), is a G protein-
coupled receptor (GPCR) that transduces the main physiological 
actions of the renin–angiotensin system in target cells. There are 
two AT1 subtypes in rodents, AT1A and AT1B. The tissue distribu-
tion of the two subtypes and knockout experiments in mice indi-
cate that cardiovascular, renal, and adrenal actions of Ang II are 
mainly mediated by AT1A; the knockout of AT1A in mice causes 
hypotension, and its overexpression by gene duplication causes 
hypertension.
Several human genetic diseases appear to be consequences of 
gain-of-function mutations of GPCR, which stabilize the receptor 
in an active conformation independent of ligand. But no evidence 
shows clear involvement of mutations of the AT1 coding sequence 
in hypertension or primary hyperaldosteronism. In a new paper, 
Billet et al. present development of a mouse with activation of 
AT1A. They constructed knock-in mice with a gain-of-function 
mutant of AT1A (Figure) by associating a constitutively activat-
ing mutation with a C-terminal deletion, which impairs receptor 
internalization and desensitization. These mice had moderately 
(∼20 mm Hg) increased blood pressure, yet developed early and 
progressive renal ﬁbrosis, cardiac ﬁbrosis, and diastolic dysfunc-
tion. Their hormonal proﬁle (low renin and inappropriately nor-
mal aldosterone production) was similar to that of low-renin 
human hypertension. This new model reveals that a constitutive 
activation of AT1A leads to cardiac and renal ﬁbrosis in spite of a 
modest eﬀect on blood pressure. The mouse is a valuable tool to 
investigate important remaining questions about the pathophysi-
ological roles of the renin–angiotensin system. (J Clin Invest 2007; 
117: 1914–1925) 
Juan Oliver
α-Klotho is a regulator of calcium 
homeostasis
Klotho mutant mice are short-lived, and the gene responsible for 
the phenotype is called klotho. This gene encodes a type I mem-
brane protein that is predominantly expressed in tissues involved 
with calcium homeostasis: the parathyroid glands, kidney, and 
choroid plexus. FGF23 is a hormone that suppresses phosphate 
reabsorption in renal proximal tubules. Recent studies have shown 
that klotho mice and mice with deletion of Fgf23 exhibit identi-
cal phenotypes, including hyperphosphatemia, hypercalcemia, 
and the aging-like syndrome. FGF23 functions are conducted 
through activation of FGF receptors for which klotho acts as 
an essential cofactor. Thus, FGF23 and klotho are emerging as 
critical regulators of mineral ion metabolism. In a recent comm-
unication, Imura et al. show a pivotal role of klotho in calcium 
homeostasis. Because a homologue of the original klotho gene 
was recently identiﬁed and named β-klotho, Imura et al. refer 
to the original gene as α-klotho. They found that the α1 subu-
nit of Na+,K+-adenosine triphosphatase (Na+,K+-ATPase) is an 
α-klotho-binding protein, which directly aﬀects Na+,K+-ATPase 
activity. The association of α-klotho with Na+,K+-ATPase (Figure) 
increased the abundance of this ATPase at the plasma mem-
brane. In the parathyroid gland, low concentrations of extracel-
lular free calcium ([Ca2+]e) rapidly induced regulated parathyroid 
hormone secretion in an α-klotho- and Na+,K+-ATPase-
dependent manner. In addition, the increased Na+ gradient 
created by Na+,K+-ATPase activity appeared to drive transepithe-
lial transport of Ca2+ in cooperation with ion channels and trans-
porters in the choroid plexus and in the kidney. Thus, α-klotho 
is an important regulator of calcium metabolism and transport, 
partially explaining the phenotype observed in α-klotho–/– 
mice and the reason that α-klotho is expressed in the tissues related 
to calcium regulation. (Science 2007; 316: 1615–1618)
Juan Oliver
Disruption of glomerular basement 
membrane charge does not alter 
glomerular permselectivity
The glomerular capillary wall is thought to function as both a 
size-selective and a charge-selective barrier. Because glomerular 
Kidney histological sections from mice, stained with Sirius red. WT, wild-
type; MUT, mutant.
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α-Klotho (αKl; green) and Na+,K+-ATPase (red) colocalization in mouse 
choroid plexus (a), kidney (b), and parathyroid glands (c).
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permeability of anionic tracers was lower than that of their neutral 
counterparts, and that of cationic forms was higher, it has long 
been assumed that an intrinsic or ‘ﬁxed’ negative charge in the cap-
illary wall poses an electrostatic barrier to anionic plasma proteins, 
such as albumin. However, these types of studies have been chal-
lenged, and whether charge selectivity is important for glomerular 
function is now debated.
Anionic sites can be detected on the basis of their aﬃnity for 
cationic probes and have been associated with each layer of the 
capillary wall. The anionic glycocalyx of podocytes and endothelial 
cells, formed largely by podocalyxin, may contribute to the bar-
rier. However, the charge of the glomerular basement membrane 
(GBM), generally considered of primary importance, is imparted 
by sulfated glycosaminoglycan side chains of proteoglycans and, 
to a lesser extent, by carboxyl and sialyl groups of glycoproteins. 
GBM anionic sites are distributed in a quasi-regular pattern along 
both laminae rarae but are most prominent along the subepithe-
lial aspect; these were identiﬁed as heparan sulfate proteoglycans 
(HSPGs). Three genetically distinct basement membrane HSPGs 
are recognized: perlecan, collagen XVIII, and agrin. Agrin is the 
predominant GBM-HSPG in all species studied. In addition, the 
isoform of agrin that is associated with basement membranes binds 
to the laminin γ1 chain at its amino terminus and to dystrogly-
can and integrin receptors through its carboxy terminus. It is thus 
thought to be an integral part of the molecular complex linking 
podocytes to the GBM.
Although agrin is the predominant GBM-HSPG, evidence show-
ing that it contributes to the charge barrier is lacking, as newborn 
agrin-deﬁcient mice die from neuromuscular defects. Harvey et 
al. used a conditional allele to generate podocyte-speciﬁc knock-
outs. Mutants were viable and displayed no renal histopathology 
up to 9 months of age. Perlecan, an HSPG normally conﬁned to 
the mesangium in mature glomeruli, did not appear in the mutant 
GBM, which lacked heparan sulfate. Moreover, GBM agrin was 
found to be derived primarily from podocytes (Figure). Polyethyl-
eneimine labeling of fetal kidneys revealed anionic sites along both 
laminae rarae of the GBM that became most prominent along the 
subepithelial aspect at maturity; labeling was greatly reduced along 
the subepithelial aspect in agrin-deﬁcient and conditional knock-
out mice. Despite this severe charge disruption, the glomerular 
ﬁltration barrier was not compromised, even when challenged with 
bovine serum albumin overload. Thus, agrin is not required for 
establishment or maintenance of GBM architecture, and, although 
agrin contributes signiﬁcantly to the anionic charge to the GBM, 
both it and its charge are not needed for glomerular permselectiv-
ity. This elegant study calls into question whether charge selectivity 
is a feature of the GBM. (Am J Pathol 2007; 171: 139–152)
Juan Oliver
Renin secretion and expression 
in mice deficient in β1- and β2-
adrenergic receptors
The juxtaglomerular (JG) cells in the media of renal aﬀerent arte-
rioles are the major sites of renin synthesis. Renin is stored in 
vesicles and released in response to speciﬁc tubular and vascular 
signals transduced by the epithelial cells of the macula densa or 
by pressure-sensitive cells in the arteriolar wall. In addition, JG 
cells are in contact with sympathetic nerve varicosities and express 
postjunctional β1-adrenergic receptors. Activation of β-adrenergic 
receptors directly increases renin secretion, even in the absence of 
changes in renal vascular tone or macula densa signals. Although 
the directional eﬀects of the main determinants of renin release are 
known, the contributions of the baroreceptor, the macula densa, 
and the renal sympathetic nerves to complex disturbances such as 
changes in body salt content have been diﬃcult to untangle.
To clarify the role of the sympathetic nerve in renin expres-
sion and release, Kim et al. examined mice without β-adrenergic 
receptors. Because the eﬀect of β-adrenergic stimulation on renin 
release is believed to be mediated by both postjunctional β1 and 
pre-junctional β2 receptors, mice deﬁcient in both β1- and β2-
adrenergic receptors (β1/β2ADR–/–) were used; this eliminated 
direct adrenergic input to JG cells. Basal renin expression and 
release was markedly reduced in the absence of β1- and β2-
adrenergic receptors. Nonetheless, regulation of renin release by 
changes in dietary salt intake was maintained, albeit at a reduced 
level. Furthermore, acute furosemide administration, or angi-
otensin inhibition, stimulated renin release in the receptor-deﬁ-
cient mice, although at reduced magnitude. Thus, β-adrenergic 
input is a major determinant of the size of the releasable renin pool 
and the absence of β-adrenergic receptors reduces the magnitude 
of the change in plasma renin by several physiological regulators. 
(Hypertension 2007; 50: 103–109)
Juan Oliver
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Podocytes of agrin mutants show no significant renal histological or 
ultrastructural abnormalities.
